UDG Healthcare (LON:UDG) was upgraded by equities researchers at Peel Hunt to a “buy” rating in a research note issued on Tuesday.

Several other equities research analysts have also recently weighed in on UDG. N+1 Singer reaffirmed a “hold” rating and issued a GBX 813 ($11.64) price target on shares of UDG Healthcare in a research note on Wednesday, February 7th. Libertas Partners raised UDG Healthcare to a “buy” rating and set a GBX 884 ($12.66) price target on the stock in a research note on Wednesday, February 7th. Liberum Capital reaffirmed a “hold” rating and issued a GBX 884 ($12.66) price target on shares of UDG Healthcare in a research note on Tuesday, January 30th. Jefferies Group reaffirmed a “hold” rating and issued a GBX 820 ($11.74) price target on shares of UDG Healthcare in a research note on Wednesday, January 17th. Finally, Numis Securities reaffirmed a “reduce” rating and issued a GBX 765 ($10.95) price target on shares of UDG Healthcare in a research note on Tuesday, January 30th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of GBX 832.63 ($11.92).

How to Become a New Pot Stock Millionaire

UDG stock traded up GBX 11.50 ($0.16) during midday trading on Tuesday, hitting GBX 886.50 ($12.69). The stock had a trading volume of 2,736,667 shares, compared to its average volume of 981,360. UDG Healthcare has a 52-week low of GBX 690 ($9.88) and a 52-week high of GBX 963 ($13.79).

In other news, insider Chris Corbin sold 730,000 shares of the stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of GBX 870 ($12.46), for a total value of £6,351,000 ($9,093,642.61).

COPYRIGHT VIOLATION WARNING: “UDG Healthcare (UDG) Stock Rating Upgraded by Peel Hunt” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.dailypolitical.com/2018/04/17/peel-hunt-upgrades-udg-healthcare-udg-to-buy.html.

UDG Healthcare Company Profile

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates through three segments: Ashfield, Sharp, and Aquilant.

Analyst Recommendations for UDG Healthcare (LON:UDG)

Receive News & Ratings for UDG Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.